首页> 外国专利> New pyrazolopyridazinone derivatives are cannabinoid receptor antagonists useful to prevent/treat psychiatric disorders, cognitive disorders, neurodegenerative diseases, metabolic disorders, dyslipidemia, pain, ulcer and tobacco weaning

New pyrazolopyridazinone derivatives are cannabinoid receptor antagonists useful to prevent/treat psychiatric disorders, cognitive disorders, neurodegenerative diseases, metabolic disorders, dyslipidemia, pain, ulcer and tobacco weaning

机译:新的吡唑并哒嗪酮衍生物是大麻素受体拮抗剂,可用于预防/治疗精神疾病,认知障碍,神经退行性疾病,代谢紊乱,血脂异常,疼痛,溃疡和烟草断奶

摘要

Pyrazolopyridazinone compounds (I), and their addition salts, hydrates and solvates are new. Pyrazolopyridazinone compounds of formula (I), and their addition salts, hydrates and solvates are new. R 11-12C alkyl (optionally substituted by F), non-aromatic 3-12C carbocyclic (optionally substituted by 1-4C alkyl, 1-4C alkoxy, F, OH, CF 3, OCF 3 or 1-4C alkylthio), phenyl (optionally substituted by halo, OH, Alk, -OAlk, methylenedioxy, -CH 2-NHAlk, -CH 2N(Alk) 2, CN, NO 2, S(O) nAlk, OS(O) nAlk, 1-4C alkylcarbonyl, 1-4C alkoxycarbonyl or phenyl, phenoxy, pyrrolyl, imidazolyl, pyridyl, pyrazolyl, oxazolyl, thiazolyl, triazolyl or thiadiazolyl, optionally substituted by 1-4C alkyl), benzyl (optionally substituted on phenyl by halo, Alk, OH, OAlk, methylenedioxy, S(O) nAlk or -OS(O) nAlk), phenethyl (optionally substituted on phenyl by halo, 1-4C alkyl, 1-4C alkoxy, CF 3 or OCF 3), benzhydryl, benzhydrylmethyl, heterocyclic aromatic comprising pyrrolyl, imidazolyl, furyl, thienyl, pyrazolyl, oxazolyl, pyridyl, indolyl, benzothienyl or thieno[3,2-b]thienyl, optionally substituted by halo, Alk, OAlk, CN, NO 2 or -S(O) nAlk; R 2phenyl (optionally substituted by halo, OH, Alk, OAlk, -S(O) nAlk or -OS(O) nAlk); R 3phenyl (optionally substituted by halo, OH, Alk, OAlk, -S(O) nAlk or OS(O) nAlk); R 4H, 1-4C alkyl, 1-4C alkoxy or OH; n : 0-2; and Alk : 1-4C alkyl (optionally substituted by F). Independent claims are included for: (1) the preparation of (I); and (2) pyrazolopyridazinone compound of formula (II). ACTIVITY : Neuroleptic; Nootropic; Tranquilizer; Neuroprotective; Metabolic; Anorectic; Antidiabetic; Analgesic; Antianginal; Antilipemic; Gastrointestinal-Gen; Antiemetic; Antidiarrheic; Antiulcer; Hepatotropic; Immunomodulator; Antiarthritic; Antirheumatic; Antiinflammatory; Antiparkinsonian; Antismoking; Antidepressant; Hypnotic; Antialcoholic; Antimigraine; Anticonvulsant; Muscular-Gen.; Inotropic; Vasotropic; Cerebroprotective; Antiaddictive; Eating-Disorders-Gen; Cardiovascular-Gen; Uropathic; Virucide; Endocrine-Gen; Hypertensive; Antiarteriosclerotic; Antibacterial; Immunosuppressive; Antiasthmatic; Respiratory-Gen; Ophthalmological; Antiinfertility; Gynecological; CNS-Gen; Osteopathic. MECHANISM OF ACTION : Cannabinoid CB 1 receptor antagonist.
机译:吡唑并吡啶并嗪酮化合物(I)及其加成盐,水合物和溶剂化物是新的。式(I)的吡唑并吡啶并嗪酮化合物及其加成盐,水合物和溶剂化物是新的。 R 11-12C烷基(可选被F取代),非芳族3-12C碳环(可选被1-4C烷基,1-4C烷氧基,F,OH,CF 3,OCF 3或1-4C烷硫基取代),苯基(可选地被卤素,OH,Alk,-OAlk,亚甲二氧基,-CH 2 -NHAlk,-CH 2N(Alk)2,CN,NO 2,S(O)nAlk,OS(O)nAlk,1-4C烷基羰基取代,1-4C烷氧基羰基或苯基,苯氧基,吡咯基,咪唑基,吡啶基,吡唑基,恶唑基,噻唑基,三唑基或噻二唑基,可选地被1-4C烷基取代),苄基(可选地在苯基上被卤素,Alk,OH,OAlk取代)亚甲二氧基,S(O)nAlk或-OS(O)nAlk),苯乙基(可选地在苯基上被卤素,1-4C烷基,1-4C烷氧基,CF 3或OCF 3取代),苯甲基,苯甲基甲基,包括吡咯基的杂环芳族化合物,咪唑基,呋喃基,噻吩基,吡唑基,恶唑基,吡啶基,吲哚基,苯并噻吩基或噻吩并[3,2-b]噻吩基,任选地被卤素,Alk,OAlk,CN,NO 2或-S(O)nAlk取代; R 2苯基(任选地被卤素,OH,Alk,OAlk,-S(O)nAlk或-OS(O)nAlk取代); R 3苯基(任选地被卤素,OH,Alk,OAlk,-S(O)nAlk或OS(O)nAlk取代); R 4H,1-4C烷基,1-4C烷氧基或OH; n:0-2; Alk:1-4C烷基(任选地被F取代)。独立索赔包括:(1)(I)的制备; (2)式(II)的吡唑并哒嗪酮化合物。活动:精神安定药;促智;镇静剂;具有神经保护作用;新陈代谢;厌食的;抗糖尿病止痛药抗心绞痛抗血脂;胃肠源;止吐药;止泻药抗溃疡;肝免疫调节剂抗关节炎抗风湿;消炎(药;反帕金森病;禁止吸烟;抗抑郁药催眠;抗酒;抗偏头痛;抗惊厥药;肌肉型;变力;变压性脑保护反吸毒饮食失调症心血管基因尿毒症;杀病毒剂;内分泌基因高血压;抗动脉硬化;抗菌;免疫抑制抗哮喘呼吸源眼科抗不孕症;妇科CNS-Gen;整骨疗法。作用机理:大麻素CB 1受体拮抗剂。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号